Form 8-K - Current report:
SEC Accession No. 0001485003-22-000006
Filing Date
2022-01-12
Accepted
2022-01-12 08:00:33
Documents
12
Period of Report
2022-01-12
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20220112.htm   iXBRL 8-K 40429
  Complete submission text file 0001485003-22-000006.txt   181809

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20220112.xsd EX-101.SCH 1914
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20220112_lab.xml EX-101.LAB 24993
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20220112_pre.xml EX-101.PRE 13190
6 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20220112_htm.xml XML 11816
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 22525590
SIC: 2834 Pharmaceutical Preparations